×
Accedi
Iniziamo
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Esplora tutte le categorie
Report -
Dermopatie in pazienti in trattamento con Imatinib mesilatoeprints.bice.rm.cnr.it/4694/1/article(21).pdfIntroduzione L’Imatinib mesilato (IM) o STI 571 rappresenta il trattamento
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form